Replies to post #235290 on NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

..and also a positive early opinion in Germany for reimbursement

I thought they got a late timescale to come up with an opinion in a further years time, several years after approval, which may or may not be positive.
They already got an early; 'we will not fund' from UK and France, some years back.

Their strategy appears to be 'charge six times what it is worth in terms of ICER's and still hope to get a third of the potential market, thereby doubling profit.'

[sentiment_stocks]

Yes but as the parade marches upward, it really must be said, “The emperor isn’t wearing any clothes!”

[Hansm7777]

I hear you, I just don't agree that those updates you discussed warrant the acute jump in pps. Then to compound it with the sale of $11.7million of shares by the CEO.

I can't wait for NWBO to finally release their top line findings where a serious debate can then held on the two approaches. Thanks for your response.

[flipper44]

NVCR did not get a "positive early opinion in Germany for reimbursement." They have to wait until October 2020 to find out if they get reimbursed in Germany. You continue to fog this issue.